Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Long-term outcome of autologous haematopoietic stem cell transplantation in patients with systemic sclerosis: a comparison with patients treated with rituximab and with traditional immunosuppressive agents

Fig. 3

Overtime changes of mRSS (a) and FVC (b) during the 5 years follow-up, performed by the analysis of the variance with repeated measures (one-way ANOVA) in patients treated with AHSCT (continuous line), RTX (dotted line) and CIT (dot line). Patients who died during the follow-up were excluded by the analysis. Data are represented as mean values and 95% CI (vertical lines) in each observation time. (a). * p < 0.001 with respect to both RTX and CIT group. (b) ^ p < 0.05 with respect to RTX group; § p < 0.005 with respect to CIT group; # p < 0.05 with respect to CIT group

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us